Current TNON stock forecast models are factoring in a 5-day moving average crossover, suggesting near-term momentum. Volatility remains below sector median, indicating controlled risk levels despite broader market uncertainty. As you were browsing something about your browser made us think you were a bot. There are a few reasons this might happen: Fintel reports that on April 9, 2025, Alliance Global Partners initiated coverage of Tenon Medical ( NasdaqCM:TNON ) with a Buy recommendation. TNON stock forecast is supported by positive analyst EPS revisions, often correlating with strong short-term performance in similar growth stocks.
